Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Madrigal Pharmaceuticals, Inc. (MDGL)

430.36 -1.34 (-0.31%)
At close: 4:00:01 PM EDT
430.36 0.00 (0.00%)
After hours: 4:00:13 PM EDT
Trade MDGL on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,283,940
958,403
180,133
0
0
Cost of Revenue
109,424
56,148
6,233
0
0
Gross Profit
1,174,516
902,255
173,900
0
0
Operating Expense
1,497,131
1,202,352
671,775
380,496
293,571
Operating Income
-322,615
-300,097
-497,875
-380,496
-293,571
Net Non Operating Interest Income Expense
3,607
15,055
31,983
6,866
-1,779
Other Income Expense
-6,087
-3,242
--
--
--
Pretax Income
-325,095
-288,284
-465,892
-373,630
-295,350
Net Income Common Stockholders
-325,095
-288,284
-465,892
-373,630
-295,350
Diluted NI Available to Com Stockholders
-325,095
-288,284
-465,892
-373,630
-295,350
Basic EPS
-13.99
-12.85
-21.90
-19.99
-17.23
Diluted EPS
-13.99
-12.85
-21.90
-19.99
-17.23
Basic Average Shares
22,899.22
22,434.31
21,272.96
18,687.77
17,137.20
Diluted Average Shares
22,899.22
22,434.31
21,272.96
18,687.77
17,137.20
Total Operating Income as Reported
-322,615
-300,097
-497,875
-380,496
-293,571
Total Expenses
1,606,555
1,258,500
678,008
380,496
293,571
Net Income from Continuing & Discontinued Operation
-325,095
-288,284
-465,892
-373,630
-295,350
Normalized Income
-322,316
-285,505
-465,892
-373,630
-295,350
Interest Income
35,114
37,364
46,654
19,578
2,185
Interest Expense
31,507
22,309
14,671
12,712
3,964
Net Interest Income
3,607
15,055
31,983
6,866
-1,779
EBIT
-293,588
-265,975
-451,221
-360,918
-291,386
EBITDA
-292,071
-264,469
-450,125
-360,391
-290,919
Reconciled Cost of Revenue
109,424
56,148
6,233
0
0
Reconciled Depreciation
1,517
1,506
1,096
527
467
Net Income from Continuing Operation Net Minority Interest
-325,095
-288,284
-465,892
-373,630
-295,350
Total Unusual Items Excluding Goodwill
-2,779
-2,779
0
0
--
Total Unusual Items
-2,779
-2,779
0
0
--
Normalized EBITDA
-289,292
-261,690
-450,125
-360,391
-290,919
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 2/6/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: